What This Means
This research suggests that among obese adults, those who screen as high-risk for obstructive sleep apnea (OSA) using a simple questionnaire called STOP-BANG are significantly more likely to have a heart condition called left ventricular diastolic dysfunction (LVDD), which is an early form of heart stiffness that can precede heart failure. In the study, 43% of obese participants had LVDD compared to only 7% of non-obese participants, and within the obese group, high OSA risk on the STOP-BANG questionnaire was associated with more than twice the odds of having LVDD even after accounting for other factors. The study also found that high-risk obese individuals tended to have more fat around the heart, higher levels of inflammatory markers in their blood, and worse autonomic nervous system function (measured through heart rate variability).
The researchers proposed that a simple three-part screening model combining the STOP-BANG score, heart fat thickness measured by ultrasound, and blood inflammatory markers could help identify obese patients who are more likely to have LVDD. This is notable because all three components are relatively easy to measure in a clinical setting. The study was conducted at a single center with 279 participants (113 obese, 166 non-obese) and used standard echocardiographic criteria to diagnose LVDD.
This research suggests that routine OSA risk screening in obese cardiac patients could help flag individuals who may need further cardiac evaluation for early heart dysfunction. However, the authors themselves caution that this cross-sectional study cannot prove that OSA causes LVDD, and the STOP-BANG questionnaire is a screening tool, not a diagnostic test for OSA. These findings point to a cluster of interconnected conditions — obesity, sleep apnea risk, heart fat, inflammation, and early heart dysfunction — that may warrant integrated screening approaches in clinical practice.